Financial Snapshot

Revenue
$28.30B
TTM
Gross Margin
77.77%
TTM
Net Earnings
$126.0M
TTM
Current Assets
$13.06B
Q3 2024
Current Liabilities
$11.73B
Q3 2024
Current Ratio
111.38%
Q3 2024
Total Assets
$54.53B
Q3 2024
Total Liabilities
$36.14B
Q3 2024
Book Value
$18.39B
Q3 2024
Cash
$5.037B
Q3 2024
P/E
905.9
Nov 29, 2024 EST
Free Cash Flow
$5.263B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Revenue $27.12B $27.28B $27.31B $24.69B $22.45B $22.13B $26.11B $30.39B $32.64B $24.89B $11.20B $9.703B $8.385B $7.949B $7.011B $5.336B $4.230B $3.026B $2.028B $1.325B $868.0M $467.0M $234.0M $196.0M $169.0M $151.0M $132.0M $33.00M $3.000M $5.000M $4.000M $4.000M $3.000M $1.000M
YoY Change -0.6% -0.09% 10.6% 9.98% 1.46% -15.24% -14.09% -6.89% 31.13% 122.19% 15.45% 15.71% 5.48% 13.38% 31.39% 26.15% 39.79% 49.21% 53.06% 52.65% 85.87% 99.57% 19.39% 15.98% 11.92% 14.39% 300.0% 1000.0% -40.0% 25.0% 0.0% 33.33% 200.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Revenue $27.12B $27.28B $27.31B $24.69B $22.45B $22.13B $26.11B $30.39B $32.64B $24.89B $11.20B $9.703B $8.385B $7.949B $7.011B $5.336B $4.230B $3.026B $2.028B $1.325B $868.0M $467.0M $234.0M $196.0M $169.0M $151.0M $132.0M $33.00M $3.000M $5.000M $4.000M $4.000M $3.000M $1.000M
Cost Of Revenue $6.019B $5.615B $6.601B $4.572B $4.675B $4.853B $4.371B $4.261B $4.006B $3.788B $2.859B $2.471B $2.124B $1.870B $1.596B $1.127B $769.0M $433.0M $260.0M $167.0M $113.0M $70.00M $44.00M $34.00M $30.00M $23.00M $22.00M $1.000M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $21.10B $21.67B $20.70B $20.12B $17.77B $17.27B $21.74B $26.13B $28.63B $21.10B $8.343B $7.232B $6.261B $6.080B $5.416B $4.209B $3.461B $2.593B $1.768B $1.158B $755.0M $397.0M $190.0M $162.0M $139.0M $128.0M $111.0M $33.00M $3.000M $5.000M $4.000M $4.000M $3.000M $1.000M
Gross Profit Margin 77.8% 79.42% 75.82% 81.48% 79.18% 78.07% 83.26% 85.98% 87.73% 84.78% 74.48% 74.53% 74.67% 76.48% 77.25% 78.88% 81.82% 85.69% 87.18% 87.4% 86.98% 85.01% 81.2% 82.65% 82.25% 84.77% 84.09% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Selling, General & Admin $6.090B $5.673B $5.246B $5.151B $4.381B $4.056B $3.878B $3.398B $3.426B $2.983B $1.699B $1.461B $1.242B $1.044B $912.0M $797.0M $706.0M $574.0M $379.0M $307.0M $233.0M $174.0M $125.0M $82.00M $99.00M $82.00M $71.00M $27.00M $9.000M $10.00M $8.000M $4.000M $2.000M $1.000M
YoY Change 7.35% 8.14% 1.84% 17.58% 8.01% 4.59% 14.13% -0.82% 14.85% 75.57% 16.29% 17.63% 18.92% 14.52% 14.43% 12.89% 23.0% 51.45% 23.45% 31.76% 33.91% 39.2% 52.44% -17.17% 20.73% 15.49% 162.96% 200.0% -10.0% 25.0% 100.0% 100.0% 100.0%
% of Gross Profit 28.87% 26.18% 25.34% 25.61% 24.65% 23.48% 17.84% 13.0% 11.97% 14.14% 20.36% 20.2% 19.84% 17.18% 16.84% 18.94% 20.4% 22.14% 21.44% 26.51% 30.86% 43.83% 65.79% 50.62% 71.22% 64.06% 63.96% 81.82% 300.0% 200.0% 200.0% 100.0% 66.67% 100.0%
Research & Development $6.875B $5.912B $5.363B $5.039B $9.106B $5.018B $3.734B $5.098B $3.014B $2.854B $2.120B $1.760B $1.229B $1.073B $914.0M $722.0M $591.0M $384.0M $278.0M $224.0M $182.0M $142.0M $186.0M $132.0M $111.0M $125.0M $112.0M $42.00M $26.00M $30.00M $26.00M $18.00M $7.000M $5.000M
YoY Change 16.29% 10.24% 6.43% -44.66% 81.47% 34.39% -26.76% 69.14% 5.61% 34.62% 20.45% 43.19% 14.56% 17.39% 26.59% 22.17% 53.91% 38.13% 24.11% 23.08% 28.17% -23.66% 40.91% 18.92% -11.2% 11.61% 166.67% 61.54% -13.33% 15.38% 44.44% 157.14% 40.0%
% of Gross Profit 32.59% 27.29% 25.9% 25.05% 51.23% 29.05% 17.18% 19.51% 10.53% 13.52% 25.41% 24.34% 19.63% 17.65% 16.88% 17.15% 17.08% 14.81% 15.72% 19.34% 24.11% 35.77% 97.89% 81.48% 79.86% 97.66% 100.9% 127.27% 866.67% 600.0% 650.0% 450.0% 233.33% 500.0%
Depreciation & Amortization $354.0M $323.0M $329.0M $288.0M $255.0M $226.0M $233.0M $177.0M $161.0M $125.0M $103.0M $83.00M $72.19M $67.24M $213.0M $156.0M $101.0M $48.00M $35.00M $24.00M $21.00M $14.00M $15.00M $12.00M $13.00M $13.00M $15.00M $4.000M $3.000M $4.000M $3.000M $2.000M $1.000M $1.000M
YoY Change 9.6% -1.82% 14.24% 12.94% 12.83% -3.0% 31.64% 9.94% 28.8% 21.36% 24.1% 14.98% 7.36% -68.43% 36.54% 54.46% 110.42% 37.14% 45.83% 14.29% 50.0% -6.67% 25.0% -7.69% 0.0% -13.33% 275.0% 33.33% -25.0% 33.33% 50.0% 100.0% 0.0%
% of Gross Profit 1.68% 1.49% 1.59% 1.43% 1.43% 1.31% 1.07% 0.68% 0.56% 0.59% 1.23% 1.15% 1.15% 1.11% 3.93% 3.71% 2.92% 1.85% 1.98% 2.07% 2.78% 3.53% 7.89% 7.41% 9.35% 10.16% 13.51% 12.12% 100.0% 80.0% 75.0% 50.0% 33.33% 100.0%
Operating Expenses $12.97B $11.59B $10.61B $10.19B $13.49B $9.074B $7.612B $8.496B $6.440B $5.837B $3.819B $3.221B $2.471B $2.117B $1.826B $1.519B $1.297B $958.0M $657.0M $530.0M $415.0M $316.0M $310.0M $214.0M $210.0M $208.0M $182.0M $68.00M $35.00M $40.00M $34.00M $22.00M $9.000M $6.000M
YoY Change 11.91% 9.2% 4.11% -24.45% 48.63% 19.21% -10.4% 31.93% 10.33% 52.84% 18.57% 30.35% 16.71% 15.95% 20.21% 17.12% 35.39% 45.81% 23.96% 27.71% 31.33% 1.94% 44.86% 1.9% 0.96% 14.29% 167.65% 94.29% -12.5% 17.65% 54.55% 144.44% 50.0%
Operating Profit $8.132B $10.08B $9.918B $4.071B $4.287B $8.200B $14.12B $17.63B $22.19B $15.27B $4.524B $4.010B $3.790B $3.962B $3.590B $2.690B $2.164B $1.635B $1.111B $628.0M $340.0M $81.00M -$120.0M -$52.00M -$71.00M -$80.00M -$71.00M -$35.00M -$32.00M -$35.00M -$30.00M -$18.00M -$6.000M -$5.000M
YoY Change -19.33% 1.64% 143.63% -5.04% -47.72% -41.94% -19.9% -20.55% 45.38% 237.42% 12.82% 5.81% -4.35% 10.37% 33.46% 24.31% 32.35% 47.16% 76.91% 84.71% 319.75% -167.5% 130.77% -26.76% -11.25% 12.68% 102.86% 9.38% -8.57% 16.67% 66.67% 200.0% 20.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Interest Expense -$944.0M -$935.0M $1.001B $984.0M $995.0M $1.077B $1.118B $964.0M $688.0M $412.0M $307.0M $361.0M $205.4M $109.0M -$70.00M -$65.00M -$63.00M -$14.00M $4.000M $6.000M -$22.00M -$30.00M -$5.000M -$4.000M -$7.000M -$7.000M -$5.000M -$1.000M -$1.000M -$1.000M $0.00 $0.00 $0.00 $0.00
YoY Change 0.96% -193.41% 1.73% -1.11% -7.61% -3.67% 15.98% 40.12% 66.99% 34.2% -14.96% 75.74% 88.52% -255.66% 7.69% 3.17% 350.0% -450.0% -33.33% -127.27% -26.67% 500.0% 25.0% -42.86% 0.0% 40.0% 400.0% 0.0% 0.0%
% of Operating Profit -11.61% -9.27% 10.09% 24.17% 23.21% 13.13% 7.92% 5.47% 3.1% 2.7% 6.79% 9.0% 5.42% 2.75% -1.95% -2.42% -2.91% -0.86% 0.36% 0.96% -6.47% -37.04%
Other Income/Expense, Net $198.0M -$581.0M -$639.0M -$1.418B $1.868B $676.0M $523.0M $428.0M $154.0M $3.000M -$9.000M -$37.00M $66.58M $60.29M $42.00M $59.00M $110.0M $135.0M $47.00M $23.00M $13.00M $22.00M $26.00M $18.00M $16.00M $22.00M $21.00M $15.00M $5.000M $5.000M $4.000M $4.000M $2.000M $1.000M
YoY Change -134.08% -9.08% -54.94% -175.91% 176.33% 29.25% 22.2% 177.92% 5033.33% -133.33% -75.68% -155.57% 10.44% 43.54% -28.81% -46.36% -18.52% 187.23% 104.35% 76.92% -40.91% -15.38% 44.44% 12.5% -27.27% 4.76% 40.0% 200.0% 0.0% 25.0% 0.0% 100.0% 100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Pretax Income $6.859B $5.814B $8.278B $1.669B $5.160B $7.074B $8.099B $7.646B $7.953B $6.678B $3.470B $3.612B $3.651B $3.914B $3.502B $2.673B $2.211B -$638.0M $1.162B $656.0M -$168.0M $73.00M $57.00M -$39.00M -$61.00M -$43.00M -$73.00M -$22.00M -$27.00M -$31.00M -$26.00M -$14.00M -$5.000M -$4.000M
YoY Change 17.97% -29.77% 395.99% -67.66% -27.06% -12.66% 5.92% -3.86% 19.09% 92.45% -3.93% -1.07% -6.71% 11.75% 31.01% 20.9% -446.55% -154.91% 77.13% -490.48% -330.14% 28.07% -246.15% -36.07% 41.86% -41.1% 231.82% -18.52% -12.9% 19.23% 85.71% 180.0% 25.0%
Income Tax $1.247B $1.248B $2.077B $1.580B -$204.0M $2.339B $8.885B $3.609B $3.553B $2.797B $1.151B $1.038B $861.9M $1.024B $876.0M $702.0M $635.0M $552.0M $348.0M $207.0M -$96.00M $1.000M $4.000M $1.000M $1.000M $1.000M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 18.18% 21.47% 25.09% 94.67% -3.95% 33.06% 109.7% 47.2% 44.67% 41.88% 33.17% 28.74% 23.61% 26.16% 25.01% 26.26% 28.72% 29.95% 31.55% 1.37% 7.02%
Net Earnings $5.665B $4.592B $6.225B $123.0M $5.386B $5.455B $4.628B $13.50B $18.11B $12.10B $3.075B $2.592B $2.804B $2.901B $2.636B $1.979B $1.585B -$1.190B $814.0M $449.0M -$72.00M $72.00M $52.00M -$57.00M -$66.00M -$45.00M -$73.00M -$22.00M -$27.00M -$31.00M -$26.00M -$14.00M -$5.000M -$4.000M
YoY Change 23.37% -26.23% 4960.98% -97.72% -1.26% 17.87% -65.72% -25.44% 49.64% 293.53% 18.63% -7.55% -3.36% 10.06% 33.2% 24.86% -233.19% -246.19% 81.29% -723.61% -200.0% 38.46% -191.23% -13.64% 46.67% -38.36% 231.82% -18.52% -12.9% 19.23% 85.71% 180.0% 25.0%
Net Earnings / Revenue 20.89% 16.83% 22.8% 0.5% 23.99% 24.65% 17.73% 44.43% 55.48% 48.62% 27.45% 26.71% 33.43% 36.5% 37.6% 37.09% 37.47% -39.33% 40.14% 33.89% -8.29% 15.42% 22.22% -29.08% -39.05% -29.8% -55.3% -66.67% -900.0% -620.0% -650.0% -350.0% -166.67% -400.0%
Basic Earnings Per Share $4.54 $3.66 $4.96 $0.10 $4.24 $4.20 $3.54 $10.08 $12.37 $7.95 $2.01 $1.71 $1.81 $1.69
Diluted Earnings Per Share $4.50 $3.639M $4.93 $0.10 $4.22 $4.17 $3.51 $9.94 $11.91 $7.35 $1.81 $1.64 $1.77 $1.66 $1.411M $1.032M $821.7K -$648.1K $429.1K $241.8K -$44.75K $43.58K $32.12K -$39.12K -$48.18K -$34.30K -$57.84K -$24.75K -$39.65K -$51.07K -$43.26K -$27.24K -$13.97K -$12.54K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Cash & Short-Term Investments $8.428B $7.630B $6.520B $7.408B $24.35B $30.09B $25.51B $11.90B $14.61B $10.13B $2.132B $1.862B $9.900B $2.099B $1.657B $1.790B $1.172B $937.0M $2.311B $1.254B $707.0M $942.0M $583.0M $513.0M $294.0M $349.0M $322.0M $296.0M $156.0M $89.00M $115.0M $139.0M $105.0M
YoY Change 10.46% 17.02% -11.99% -69.58% -19.07% 17.95% 114.46% -18.57% 44.23% 375.05% 14.5% -81.19% 371.65% 26.67% -7.43% 52.73% 25.08% -59.45% 84.29% 77.37% -24.95% 61.58% 13.65% 74.49% -15.76% 8.39% 8.78% 89.74% 75.28% -22.61% -17.27% 32.38%
Cash & Equivalents $8.428B $7.630B $5.338B $5.997B $11.63B $17.94B $7.588B $8.229B $12.85B $10.03B $2.113B $1.804B $9.884B $908.0M $1.273B $1.459B $968.0M $816.0M $708.0M $281.0M $195.0M $617.0M $123.0M $197.0M $47.00M $101.0M $32.00M $132.0M $27.00M $30.00M $13.00M $2.000M $88.00M
Short-Term Investments $1.179B $973.0M $1.182B $1.411B $12.72B $12.15B $17.92B $3.666B $1.757B $101.0M $19.00M $59.00M $16.00M $1.191B $384.0M $331.0M $204.0M $121.0M $1.603B $973.0M $512.0M $325.0M $459.0M $316.0M $247.0M $248.0M $290.0M $164.0M $128.0M $59.00M $102.0M $137.0M $17.00M
Other Short-Term Assets $2.374B $1.774B $2.141B $2.013B $1.440B $1.606B $1.661B $1.592B $2.345B $1.565B $986.0M $798.0M $677.0M $784.0M $714.0M $537.0M $461.0M $319.0M $168.0M $88.00M $226.0M $15.00M $11.00M $12.00M $11.00M $9.000M $18.00M $4.000M $2.000M $2.000M $2.000M $1.000M $1.000M
YoY Change 33.82% -17.14% 6.36% 39.79% -10.34% -3.31% 4.33% -32.11% 49.84% 58.72% 23.56% 17.87% -13.65% 9.8% 32.96% 16.49% 44.51% 89.88% 90.91% -61.06% 1406.67% 36.36% -8.33% 9.09% 22.22% -50.0% 350.0% 100.0% 0.0% 0.0% 100.0% 0.0%
Inventory $3.366B $2.820B $1.618B $1.683B $922.0M $814.0M $801.0M $1.587B $1.955B $1.386B $1.697B $1.745B $1.390B $1.204B $1.052B $928.0M $600.0M $564.0M $217.0M $136.0M $98.00M $52.00M $39.00M $21.00M $21.00M $17.00M
Prepaid Expenses
Receivables $4.660B $4.777B $4.493B $4.892B $3.582B $3.327B $3.851B $4.514B $5.854B $4.635B $2.182B $1.751B $1.951B $1.622B $1.390B $1.023B $795.0M $609.0M $396.0M $371.0M $235.0M $125.0M $74.00M $49.00M $46.00M $43.00M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $50.00M $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $16.45B $15.23B $14.77B $16.00B $30.30B $35.84B $31.82B $19.59B $24.76B $17.71B $6.997B $6.156B $13.92B $5.708B $4.813B $4.278B $3.028B $2.429B $3.092B $1.850B $1.266B $1.184B $708.0M $594.0M $372.0M $417.0M $340.0M $300.0M $157.0M $91.00M $117.0M $140.0M $106.0M
YoY Change 8.06% 3.08% -7.65% -47.2% -15.46% 12.61% 62.46% -20.89% 39.79% 153.17% 13.66% -55.77% 143.85% 18.6% 12.51% 41.28% 24.66% -21.44% 67.14% 46.13% 6.93% 67.23% 19.19% 59.68% -10.79% 22.65% 13.33% 91.08% 72.53% -22.22% -16.43% 32.08%
Property, Plant & Equipment $5.317B $5.475B $5.663B $5.613B $5.170B $4.006B $3.295B $2.865B $2.276B $1.674B $1.166B $1.100B $774.0M $701.0M $700.0M $529.0M $448.0M $361.0M $243.0M $223.0M $198.0M $68.00M $63.00M $55.00M $51.00M $51.00M $10.00M $9.000M $8.000M $10.00M $9.000M $6.000M $2.000M
YoY Change -2.89% -3.32% 0.89% 8.57% 29.06% 21.58% 15.01% 25.88% 35.96% 43.57% 6.0% 42.12% 10.41% 0.14% 32.33% 18.08% 24.1% 48.56% 8.97% 12.63% 191.18% 7.94% 14.55% 7.84% 0.0% 410.0% 11.11% 12.5% -20.0% 11.11% 50.0% 200.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.163B $1.245B $1.309B $502.0M $1.488B $1.423B $11.19B $20.50B $11.60B $1.598B $439.0M $720.0M $64.00M $3.219B $2.248B $1.450B $1.550B $453.0M $2.000M
YoY Change -6.59% -4.89% 160.76% -66.26% 4.57% -87.29% -45.38% 76.67% 625.97% 264.01% -39.03% 1025.0% -98.01% 43.19% 55.03% -6.45% 242.16% 22550.0%
Other Assets $5.586B $5.261B $4.421B $5.062B $6.770B $2.555B $2.712B $3.886B $1.658B $1.433B $908.0M $466.0M $479.0M $538.0M $413.0M $557.0M $808.0M $843.0M $430.0M $83.00M $91.00M $37.00M $24.00M $29.00M $13.00M $20.00M $1.000M $1.000M $1.000M $1.000M $1.000M $0.00 $0.00
YoY Change 6.18% 19.0% -12.66% -25.23% 164.97% -5.79% -30.21% 134.38% 15.7% 57.82% 94.85% -2.71% -10.97% 30.27% -25.85% -31.06% -4.15% 96.05% 418.07% -8.79% 145.95% 54.17% -17.24% 123.08% -35.0% 1900.0% 0.0% 0.0% 0.0% 0.0%
Total Long-Term Assets $45.67B $47.94B $53.18B $52.41B $31.33B $27.84B $38.46B $37.39B $26.95B $16.95B $15.58B $15.08B $3.384B $5.885B $4.886B $2.659B $2.807B $1.657B $674.0M $306.0M $289.0M $104.0M $87.00M $84.00M $65.00M $71.00M $12.00M $11.00M $10.00M $11.00M $10.00M $7.000M $3.000M
YoY Change -4.74% -9.85% 1.47% 67.28% 12.54% -27.62% 2.86% 38.71% 59.02% 8.78% 3.3% 345.74% -42.5% 20.45% 83.75% -5.27% 69.4% 145.85% 120.26% 5.88% 177.88% 19.54% 3.57% 29.23% -8.45% 491.67% 9.09% 10.0% -9.09% 10.0% 42.86% 133.33%
Total Assets $62.13B $63.17B $67.95B $68.41B $61.63B $63.68B $70.28B $56.98B $51.72B $34.66B $22.58B $21.24B $17.30B $11.59B $9.699B $6.937B $5.835B $4.086B $3.766B $2.156B $1.555B $1.288B $795.0M $678.0M $437.0M $488.0M $352.0M $311.0M $167.0M $102.0M $127.0M $147.0M $109.0M
YoY Change
Accounts Payable $550.0M $905.0M $705.0M $844.0M $713.0M $790.0M $814.0M $1.206B $1.178B $955.0M $1.256B $1.327B $1.206B $803.0M $811.0M $601.0M $290.0M $367.0M $71.00M $48.00M $36.00M $24.00M $19.00M $12.00M $9.000M $8.000M $3.000M $3.000M $2.000M $1.000M $1.000M $1.000M $0.00
YoY Change -39.23% 28.37% -16.47% 18.37% -9.75% -2.95% -32.5% 2.38% 23.35% -23.96% -5.35% 10.03% 50.19% -0.99% 34.94% 107.24% -20.98% 416.9% 47.92% 33.33% 50.0% 26.32% 58.33% 33.33% 12.5% 166.67% 0.0% 50.0% 100.0% 0.0% 0.0%
Accrued Expenses $7.724B $7.100B $7.600B $7.198B $6.254B $6.876B $7.271B $7.775B $7.257B $4.084B $2.246B $1.570B $1.187B $911.0M $765.0M $526.0M $415.0M $334.0M $220.0M $177.0M $145.0M $73.00M $55.00M $39.00M $30.00M $42.00M $19.00M $9.000M $6.000M $6.000M $6.000M $4.000M $1.000M
YoY Change 8.79% -6.58% 5.58% 15.09% -9.05% -5.43% -6.48% 7.14% 77.69% 81.83% 43.06% 32.27% 30.3% 19.08% 45.44% 26.75% 24.25% 51.82% 24.29% 22.07% 98.63% 32.73% 41.03% 30.0% -28.57% 121.05% 111.11% 50.0% 0.0% 0.0% 50.0% 300.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.798B $2.273B $1.516B $2.757B $2.499B $2.748B $2.747B $0.00 $982.0M $483.0M $2.697B $1.169B $2.000M $646.0M $6.000M $6.000M $0.00 $19.00M $60.00M $0.00 $0.00 $0.00 $1.000M $3.000M $3.000M $5.000M $2.000M $4.000M $3.000M $3.000M $1.000M $1.000M $0.00
YoY Change -20.9% 49.93% -45.01% 10.32% -9.06% 0.04% -100.0% 103.31% -82.09% 130.71% 58350.0% -99.69% 10666.67% 0.0% -100.0% -68.33% -100.0% -66.67% 0.0% -40.0% 150.0% -50.0% 33.33% 0.0% 200.0% 0.0%
Total Short-Term Liabilities $11.28B $11.24B $11.61B $11.40B $9.759B $10.61B $11.64B $9.218B $9.890B $5.761B $6.407B $4.238B $2.515B $2.465B $1.872B $1.221B $736.0M $764.0M $465.0M $253.0M $186.0M $105.0M $80.00M $58.00M $48.00M $57.00M $33.00M $16.00M $12.00M $11.00M $9.000M $6.000M $2.000M
YoY Change 0.38% -3.21% 1.87% 16.78% -7.98% -8.85% 26.22% -6.79% 71.67% -10.08% 51.18% 68.51% 2.03% 31.68% 53.32% 65.9% -3.66% 64.3% 83.79% 36.02% 77.14% 31.25% 37.93% 20.83% -15.79% 72.73% 106.25% 33.33% 9.09% 22.22% 50.0% 200.0%
Long-Term Debt $23.19B $22.96B $25.18B $28.65B $22.09B $24.57B $30.80B $26.35B $21.08B $11.94B $4.003B $7.062B $7.606B $2.839B $1.155B $1.098B $1.300B $1.300B $0.00 $0.00 $345.0M $595.0M $250.0M $252.0M $85.00M $89.00M $1.000M $3.000M $3.000M $5.000M $2.000M $1.000M $1.000M
YoY Change 1.01% -8.82% -12.1% 29.65% -10.09% -20.2% 16.89% 25.01% 76.57% 198.18% -43.32% -7.15% 167.91% 145.8% 5.19% -15.54% 0.0% -100.0% -42.02% 138.0% -0.79% 196.47% -4.49% 8800.0% -66.67% 0.0% -40.0% 150.0% 100.0% 0.0%
Other Long-Term Liabilities $28.10B $30.73B $5.743B $10.14B $7.124B $6.962B $7.352B $2.050B $1.638B $1.097B $341.0M $386.0M $315.0M $167.0M $166.0M $152.0M $198.0M $153.0M $273.0M $31.00M $21.00M $17.00M $12.00M $16.00M $7.000M $8.000M
YoY Change -8.56% 435.0% -43.39% 42.39% 2.33% -5.3% 258.63% 25.15% 49.32% 221.7% -11.66% 22.54% 88.62% 0.6% 9.21% -23.23% 29.41% -43.96% 780.65% 47.62% 23.53% 41.67% -25.0% 128.57% -12.5%
Total Long-Term Liabilities $28.10B $30.73B $30.92B $38.79B $29.22B $31.54B $38.15B $28.40B $22.71B $13.03B $4.344B $7.448B $7.921B $3.006B $1.321B $1.250B $1.498B $1.453B $273.0M $31.00M $366.0M $612.0M $262.0M $268.0M $92.00M $97.00M $1.000M $3.000M $3.000M $5.000M $2.000M $1.000M $1.000M
YoY Change -8.56% -0.64% -20.28% 32.76% -7.35% -17.33% 34.34% 25.02% 74.27% 200.02% -41.68% -5.97% 163.51% 127.55% 5.68% -16.56% 3.1% 432.23% 780.65% -91.53% -40.2% 133.59% -2.24% 191.3% -5.15% 9600.0% -66.67% 0.0% -40.0% 150.0% 100.0% 0.0%
Total Liabilities $39.38B $41.96B $46.88B $50.21B $39.10B $42.29B $49.84B $38.09B $33.18B $19.24B $11.21B $11.94B $10.56B $5.729B $3.331B $2.664B $2.375B $2.270B $739.0M $285.0M $552.0M $717.0M $342.0M $327.0M $140.0M $154.0M $35.00M $19.00M $15.00M $16.00M $11.00M $7.000M $3.000M
YoY Change -6.16% -10.5% -6.62% 28.39% -7.53% -15.15% 30.85% 14.79% 72.48% 71.63% -6.1% 13.0% 84.4% 71.99% 25.04% 12.17% 4.63% 207.17% 159.3% -48.37% -23.01% 109.65% 4.59% 133.57% -9.09% 340.0% 84.21% 26.67% -6.25% 45.45% 57.14% 133.33%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $114.15 Billion

About GILEAD SCIENCES, INC.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 18,000 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. The company is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The firm operates in more than 35 countries.

Industry: Biological Products, (No Diagnostic Substances) Peers: AbbVie Inc. AMGEN INC BIOGEN INC. Moderna, Inc. REGENERON PHARMACEUTICALS, INC. VERTEX PHARMACEUTICALS INC / MA